We’ve recently updated our valuation analysis.

NanoXplore Valuation

Is GRA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GRA?

Other financial metrics that can be useful for relative valuation.

GRA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.5x
Enterprise Value/EBITDA-45.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does GRA's PS Ratio compare to its peers?

The above table shows the PS ratio for GRA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.5x
BOS AirBoss of America
0.4x-1.8%CA$295.0m
CHE.UN Chemtrade Logistics Income Fund
0.7x1.2%CA$1.2b
MX Methanex
0.7x1.3%CA$4.4b
FRXI FRX Innovations
4.2x68.8%CA$27.3m
GRA NanoXplore
4.6x33.8%CA$475.6m

Price-To-Sales vs Peers: GRA is expensive based on its Price-To-Sales Ratio (4.6x) compared to the peer average (1.5x).


Price to Earnings Ratio vs Industry

How does GRA's PE Ratio compare vs other companies in the CA Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-28.0%
n/an/an/a

Price-To-Sales vs Industry: GRA is expensive based on its Price-To-Sales Ratio (4.6x) compared to the Canadian Chemicals industry average (3.1x)


Price to Sales Ratio vs Fair Ratio

What is GRA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GRA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.6x
Fair PS Ratio1.8x

Price-To-Sales vs Fair Ratio: GRA is expensive based on its Price-To-Sales Ratio (4.6x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).


Share Price vs Fair Value

What is the Fair Price of GRA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GRA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GRA's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GRA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$2.95
CA$6.54
+121.5%
23.5%CA$10.00CA$5.00n/a7
Jan ’24CA$2.60
CA$6.82
+162.4%
23.4%CA$10.00CA$5.00n/a7
Dec ’23CA$2.78
CA$7.36
+164.6%
37.7%CA$13.75CA$5.00n/a7
Nov ’23CA$3.35
CA$8.22
+145.4%
31.4%CA$13.75CA$6.00n/a7
Oct ’23CA$3.21
CA$8.59
+167.7%
30.4%CA$13.75CA$6.00n/a6
Sep ’23CA$3.84
CA$8.59
+123.7%
30.4%CA$13.75CA$6.00n/a6
Aug ’23CA$3.67
CA$8.59
+134.1%
30.4%CA$13.75CA$6.00n/a6
Jul ’23CA$3.29
CA$8.59
+161.1%
30.4%CA$13.75CA$6.00n/a6
Jun ’23CA$4.43
CA$8.59
+93.9%
30.4%CA$13.75CA$6.00n/a6
May ’23CA$3.21
CA$9.72
+202.7%
19.5%CA$13.75CA$8.25n/a6
Apr ’23CA$4.45
CA$9.72
+118.4%
19.5%CA$13.75CA$8.25n/a6
Mar ’23CA$4.14
CA$9.75
+135.5%
19.4%CA$13.75CA$8.25n/a6
Feb ’23CA$5.55
CA$10.21
+83.9%
16.3%CA$13.75CA$8.50CA$2.956
Jan ’23CA$6.53
CA$10.29
+57.6%
15.9%CA$13.75CA$8.50CA$2.606
Dec ’22CA$5.95
CA$9.88
+66.0%
20.3%CA$13.75CA$7.50CA$2.786
Nov ’22CA$7.85
CA$9.54
+21.5%
22.3%CA$13.75CA$7.50CA$3.356
Oct ’22CA$6.81
CA$8.71
+27.9%
30.8%CA$13.75CA$5.00CA$3.216
Sep ’22CA$6.02
CA$7.88
+30.8%
39.9%CA$13.75CA$5.00CA$3.846
Aug ’22CA$4.67
CA$6.96
+49.0%
44.1%CA$13.75CA$5.00CA$3.676
Jul ’22CA$4.47
CA$6.42
+43.5%
29.3%CA$10.50CA$5.00CA$3.296
Jun ’22CA$3.38
CA$6.25
+84.9%
31.2%CA$10.50CA$5.00CA$4.436
May ’22CA$3.99
CA$6.25
+56.6%
31.2%CA$10.50CA$5.00CA$3.216
Apr ’22CA$3.23
CA$6.36
+97.0%
34.6%CA$11.18CA$5.00CA$4.456
Mar ’22CA$3.72
CA$6.25
+68.0%
31.2%CA$10.50CA$5.00CA$4.146
Feb ’22CA$3.93
CA$5.60
+42.5%
44.2%CA$10.50CA$4.00CA$5.555

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies